Get App Open
In App
Credit Cards
Open App
you are here:

Piramal Pharma Ltd.

BSE: 543635 | NSE: PPLPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE0DK501011 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Oct 01, 16:01
199.30 8.40 (4.40%)
Volume
AVERAGE VOLUME
5-Day
202,141
10-Day
181,871
30-Day
347,882
316,480
  • Prev. Close

    190.90

  • Open Price

    190.85

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 01, 15:59
199.04 7.88 (4.12%)
Volume
AVERAGE VOLUME
5-Day
2,515,762
10-Day
2,308,888
30-Day
5,167,622
5,460,929
  • Prev. Close

    191.16

  • Open Price

    191.07

  • Bid Price (Qty.)

    199.04 (311)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Profit & Loss account of Piramal Pharma (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 13 mths  
INCOME  
Revenue From Operations [Gross] 5,202.56 4,325.31 3,349.59 2,977.57 2,899.75  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 5,202.56 4,325.31 3,349.59 2,977.57 2,899.75  
Total Operating Revenues 5,285.71 4,390.11 3,443.22 3,094.95 2,938.81  
Other Income 207.35 202.06 341.07 223.59 197.97  
Total Revenue 5,493.06 4,592.17 3,784.29 3,318.54 3,136.78  
EXPENSES  
Cost Of Materials Consumed 1,596.93 1,545.55 1,166.48 1,003.68 986.70  
Purchase Of Stock-In Trade 733.60 624.91 548.69 509.70 183.21  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -84.57 -61.62 53.31 -30.17 57.86  
Employee Benefit Expenses 736.19 613.93 548.50 425.30 395.15  
Finance Costs 114.56 107.10 115.87 53.55 4.71  
Depreciation And Amortisation Expenses 222.09 205.26 192.08 130.64 143.64  
Other Expenses 1,263.12 1,049.42 1,028.71 789.14 696.96  
Total Expenses 4,581.92 4,084.55 3,653.64 2,881.84 2,468.23  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 911.14 507.62 130.65 436.70 668.55  
Exceptional Items 0.00 0.00 -6.96 -12.47 18.23  
Profit/Loss Before Tax 911.14 507.62 123.69 424.23 686.78  
Tax Expenses-Continued Operations  
Current Tax 199.44 112.48 38.77 96.34 104.98  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax 20.30 3.92 15.42 -15.16 10.30  
Tax For Earlier Years 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 219.74 116.40 54.19 81.18 115.28  
Profit/Loss After Tax And Before ExtraOrdinary Items 691.40 391.22 69.50 343.05 571.50  
Profit/Loss From Continuing Operations 691.40 391.22 69.50 343.05 571.50  
Profit/Loss For The Period 691.40 391.22 69.50 343.05 571.50  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 5.22 3.05 0.58 2.91 9.11  
Diluted EPS (Rs.) 5.20 3.05 0.58 2.91 9.11  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 14.47 0.00 0.00 0.00 0.00  
Tax On Dividend 0.00 0.00 0.00 0.00 0.00  
Equity Dividend Rate (%) 1.00 1.00 0.00 0.00 0.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970